Residual disease assessment in hematologic malignancies to improve patient-relevant outcomes across Europe (RESOLVE)

Ref: RESOLVE. 101136502

PI:

Start: 2024-01-01 | End: 2028-12-31

Armonización e integración estratégica de datos en ciencias ómicas para una medicina de precisión en Leucemia Aguda Linfoblástica B.

Ref: SA198P24

PI: Jesús María Hernández Rivas (PI)

Start: 2024-08-30 | End: 2028-02-29

Estudio metabolómico y epigenómico de la LLC con trisomía 12 para identificar mecanismos de resistencia a fármacos y definir potenciales dianas terapéuticas mediante modelos in vitro y ex vivo.

Ref: PI24/01432

PI: Ana Eugenia Rodríguez Vicente

Start: 2025-01-01 | End: 2027-12-31

Estudio de la evolución clonal en Leucemia Linfoblástica Aguda B mediante metodologías ómicas: Next Generation Sequencing (NGS) y Optical Genome Mapping (OGM). Implicaciones en la resistencia al tratamiento

Ref: GRS2823/A1/2023

PI: Susana Riesco

Start: 2024-04-19 | End: 2024-12-31

Building the EU Cancer and Health Genomics platform. CAN.HEAL

Ref: CAN-HEAL. 101080009

PI: Marc Van den Bulcke (Sciensano

Start: 2022-11-01 | End: 2024-10-31

Genomic and functional analysis of mutations, fusion results and variations in the number of copies, through massive sequencing as well as in-vitro and in-vivo studies: implications in B-Cell Acute lymphoblastic leukemia (B-ALL)

Ref: SA118P20

PI: JM Hernández-Rivas

Start: 2020-11-06 | End: 2023-10-31

Harmony Plus.Healthcare alliance for resourceful medicines offensive against neoplasms in hematology – PLUS

Ref: HARMONY PLUS (945406)

PI: Jesús María Hernández Rivas

Start: 2020-10-01 | End: 2023-09-30

Harmony Fundation

Ref:

PI: Jesús María Hernández Rivas (President)

Start: 2021-05-01

Ref:

PI: -

Start: 2020-03-15

Atlas Genetics Oncology

Ref:

PI: Jesús M. Hernández Rivas, Paola Dal Cin (Editors in chief)

Start: 2019-06-10